Jiangsu Hengrui Receives NMPA Approval for SHR-2173 Clinical Trial in ITP
CompanyDrug

Jiangsu Hengrui Receives NMPA Approval for SHR-2173 Clinical Trial in ITP

Eisai and Biogen's Lecanemab Receives Positive CHMP Opinion for Early Alzheimer's Treatment
CompanyDrug

Eisai and Biogen’s Lecanemab Receives Positive CHMP Opinion for Early Alzheimer’s Treatment

Merck Secures Exclusive Rights to LaNova's PD-1/VEGF Bispecific Antibody LM-299
Policy / Regulatory

Merck Secures Exclusive Rights to LaNova’s PD-1/VEGF Bispecific Antibody LM-299

China Releases Comprehensive AI Application Guidelines for Healthcare Industry
Policy / Regulatory

China Releases Comprehensive AI Application Guidelines for Healthcare Industry

BeiGene Ltd to Become BeOne Medicines Ltd, Emphasizing Global Oncology Commitment
Company

BeiGene Ltd to Become BeOne Medicines Ltd, Emphasizing Global Oncology Commitment

Beijing Biostar Partners with Baheal for Utidelone Market Promotion in China
CompanyDeals

Beijing Biostar Partners with Baheal for Utidelone Market Promotion in China

NMPA Issues Interim Provisions for Overseas MAHs' Designated Domestic Responsible Persons
Policy / Regulatory

NMPA Issues Interim Provisions for Overseas MAHs’ Designated Domestic Responsible Persons

Sino Biopharmaceutical's TQB3002 Receives FDA Clearance for Phase I Study
CompanyDrug

Sino Biopharmaceutical’s TQB3002 Receives FDA Clearance for Phase I Study

PegBio Files for IPO on Hong Kong Stock Exchange
CompanyDeals

PegBio Files for IPO on Hong Kong Stock Exchange

Mabwell Bioscience Receives NMPA Approval for 9MW2821 Clinical Trials
CompanyDrug

Mabwell Bioscience Receives NMPA Approval for 9MW2821 Clinical Trials

WuXi Biologics Expands Sterile Filling Capabilities in Germany with New Line
CompanyDrug

WuXi Biologics Expands Sterile Filling Capabilities in Germany with New Line

Jiangxi Jemincare's JMX-2002 Liposome Injection Gets NMPA Clinical Clearance
CompanyDrug

Jiangxi Jemincare’s JMX-2002 Liposome Injection Gets NMPA Clinical Clearance